Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SOCA
SELLSolarius Capital Acquisition Corp. · Financial Services · United States · $242M · Avg Vol: $193K/d
COMPANY DESCRIPTION
Solarius Capital Acquisition Corp. is a special purpose acquisition company (SPAC) established to merge with or acquire an operating business. As a blank check company, it possesses no ongoing operations or revenue, with its value proposition resting on its management team's ability to identify and successfully execute a strategic business combination. Its market position is currently defined by its search for a suitable merger target.
FINANCIAL SUMMARY (USD)
| Year | 2025 | TTM |
|---|---|---|
| Revenue | — | — |
| EPS | — | — |
| Shares | 23.4M | 17.7M |
| Debt | — | — |
| Equity | 169.7M | — |
| Op CF | — | — |
| Inv CF | — | — |
| Fin CF | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of SOCA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SOCA | Solarius Capital Acquisition Corp.(you) | $242M | 31 | SELL |
| SVCC | Stellar V Capital Corp. | $229M | 31 | SELL |
| FIGX | FIGX Capital Acquisition Corp. | $199M | 30 | SELL |
| MKLY | McKinley Acquisition Corporation | $315M | 30 | SELL |
| HVMC | Highview Merger Corp. | $300M | 29 | SELL |
| NTWO | Newbury Street II Acquisition Corp | $256M | 26 | SELL |
| VNME | Vendome Acquisition Corporation I | $254M | 25 | SELL |
| DMAA | Drugs Made In America Acquisition Corp. | $260M | 25 | SELL |
| GTERA | Globa Terra Acquisition Corporation | $306M | 27 | SELL |
| PAII | Pyrophyte Acquisition Corp. II | $353M | 29 | SELL |
Peer medians: ROE 9.4% · P/E 13.9x · Gross margin 100.0%